Adrian Johnson

Summary of Diagon Raises $5.1 Million to Revolutionize Manufacturing Procurement TLDR: Diagon raises $5.1 million in seed funding to revolutionize manufacturing procurement Platform streamlines the procurement process for manufacturers Diagon, a company

TLDR: Crypto.com’s venture capital arm is cautious about inflated valuations in crypto startups, while VCs are shifting focus toward AI. Recent uptick in investments by cryptocurrency venture capital companies has prompted concerns

TLDR: Metsera, a weight-loss drug developer, has raised $290 million in funding led by ARCH Venture Partners. The company is developing injectable and oral drugs to treat obesity based on the GLP-1

TLDR: Key Points: CairoScene article highlights various events, developments, and releases happening in the arts and culture scene in Egypt and Saudi Arabia. Notable mentions include exhibitions at Milan Design Week, upcoming

TLDR: Beltone Venture Capital and UAE-Based Citadel Holding have launched a $30M fund to support startups in the MENA region. The fund will focus on pre-seed and seed funding rounds for innovative

Article Summary TLDR: The Federal Reserve is expected to keep interest rates steady for longer than anticipated. Chair Jerome Powell indicated that rate cuts may not happen soon due to ongoing inflation

TLDR: Riga-based fintech startup inGain raises €650k in funding from Trind VC, Fiedler Capital, Latvian Business Angels network, and business angels. inGain offers a no-code SaaS loan management system to enable companies

TLDR: Kelly Perdew and Craig Cummings successfully transitioned from military careers to venture capital. Veterans bring valuable skills and experiences to the VC ecosystem. From Battlefields To Boardrooms: The Rise Of Military

TLDR: Venture capital funding for cryptocurrency and blockchain projects saw a 58% increase in Q1 2024. Investors with a long-term thesis are deploying capital in the Web3 space. Venture capital funding for

TLDR: Metsera, a newly emerged biotech funded with $290 million, aims to revolutionize obesity and metabolic disease treatments by creating customizable combinations of injectable and oral peptides. The company was launched during